SAGE Open Medical Case Reports (May 2024)

Medical management of ectopic pregnancy: Case series at a private tertiary hospital, Tanzania

  • Gregory Ntiyakunze,
  • Daudi Gidion,
  • Willbroad Kyejo,
  • Brenda Moshi,
  • Shweta Jaiswal,
  • Lynn Moshi,
  • Jane Muzo,
  • Harrison Chuwa,
  • Muzdalifat Abeid

DOI
https://doi.org/10.1177/2050313X241252348
Journal volume & issue
Vol. 12

Abstract

Read online

Ectopic pregnancy is a pregnancy in which the developing blastocyst implants outside the endometrial cavity. An estimated 1.3%–2.4% of pregnancies end up outside the uterus. With prompt diagnosis and efficient treatment, the risks of morbidity and mortality associated with ectopic pregnancy can be reduced. For the treatment of carefully chosen ectopic pregnancies, methotrexate therapy, a folic acid antagonist that is highly toxic to rapidly replicating tissues, produces outcomes comparable to surgery. We describe six cases of ectopic pregnancy which were successfully treated with methotrexate and on follow-up two of them successfully conceived to term delivery. For patients who are physically fit enough, medical management of an ectopic pregnancy with methotrexate should be the first line of treatment to lower surgical morbidity and mortality. Following the administration of the medication, the patient is monitored with a clinical symptom interview and weekly plasma human chorionic gonadotrophin levels checks. When initial human chorionic gonadotrophin levels are extremely high, complete resolution of an ectopic pregnancy can take 6–8 weeks instead of the usual 2–3 weeks. Early diagnosis of ectopic pregnancies is necessary to improve their prognosis. Ectopic pregnancies can be managed medically with methotrexate to preserve fertility. Compared to surgical management, methotrexate therapy appears to have more advantages.